$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Can venetoclax/venetoclax cure leukemia?
2026-02-01 22:25:32
Check Details
How to identify the authenticity of Venetoclax/Venetoclax
2026-02-01 22:25:32
Check Details
How much does venetoclax/venetoclax cost per month?
2026-02-01 22:25:32
Check Details
Can Venetoclax/Venetoclax be used by children?
2026-02-01 22:25:32
Check Details
Is venetoclax/venetoclax a chemotherapy drug or a maintenance drug?
2026-02-01 22:25:32
Check Details
Lapatinib clinical trial introduction
2026-02-01 22:25:32
Check Details
How effective is lapatinib?
2026-02-01 22:25:32
Check Details
Common adverse reactions and coping strategies of lapatinib
2026-02-01 22:25:32
Check Details
Pitobrutinib dosage and precautions
2026-02-01 22:25:32
Check Details
What are the contraindications and precautions for Pitobrutinib?
2026-02-01 22:25:32
Check Details
Pitobrutinib adverse reactions
2026-02-01 22:25:32
Check Details
What is the selling price of Serpatinib?
2026-02-01 22:25:32
Check Details
1
2
...
1174
1175
1176
1177
1178
1179
1180
...
2439
2440
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Approves Orzeyful, the World's First Orexin Receptor Agonist for Narcolepsy Type 1, Ushering in a New Era of Root-Cause Therapy
2
FDA Approves Lytenava: First Ophthalmic Bevacizumab for Wet AMD
3
AbbVie’s TEPKINLY (epcoritamab) Plus R² Granted EU Approval for Relapsed/Refractory Follicular Lymphoma
4
Global Oncology Update: Breakthroughs in Advanced Cancer Survival and Novel Therapies
5
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
6
Global Breakthroughs in Cancer Drugs and Advanced Treatment Technologies
7
ROS and Cancer: The Potential of Natural Antioxidants
8
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
9
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
10
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
11
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
12
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial